Quinoxalinone as a Privileged Platform in Drug Development

Mini Rev Med Chem. 2018 Feb 14;18(5):392-413. doi: 10.2174/1389557517666171101111134.

Abstract

Among the family of nitrogen-containing heterocycles, quinoxalinone (or quinoxalin-2-one) core, characterized by pyrazin-2(1H)-one fused to benzene ring at two adjacent carbon atoms, has been frequently found in a variety of pharmacologically active compounds with biological or pharmaceutical applications. It was gratifying that a larger part of these bioactive quinoxalinone-based derivatives has entered various clinical trials, which in turn hastens the synthetic versatility and also initiates various derivatization of quinoxalinone scaffold. In this review, we highlighted the newly emerged quinoxalinone- based derivatives or analogues, with the emphasis of their biological applications and structure-activity analysis covering literatures in recent years.

Keywords: Binding mode; SAR analysis.; biological activities; derivates; quinoxaline; quinoxalinone skeleton.

Publication types

  • Review

MeSH terms

  • Anti-Infective Agents / chemical synthesis
  • Anti-Infective Agents / chemistry
  • Anti-Infective Agents / pharmacology*
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Bacteria / drug effects
  • Drug Design*
  • Enzyme Inhibitors / chemical synthesis
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Fungi / drug effects
  • Humans
  • Molecular Structure
  • Neoplasms / drug therapy*
  • Quinoxalines / chemical synthesis
  • Quinoxalines / chemistry
  • Quinoxalines / pharmacology*

Substances

  • Anti-Infective Agents
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Quinoxalines